16885042

Source:http://linkedlifedata.com/resource/pubmed/id/16885042

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023981, umls-concept:C0026987, umls-concept:C0027013, umls-concept:C0034656, umls-concept:C0039736, umls-concept:C1096776, umls-concept:C1696465
pubmed:issue	8
pubmed:dateCreated	2006-8-3
pubmed:abstractText	In non-randomized studies, thalidomide appeared to be effective in myeloid metaplasia with myelofibrosis (MMM). We compared thalidomide to placebo for treatment of anemia in MMM.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0417435
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1592-8721
pubmed:author	pubmed-author:AbgrallJean-FrançoisJF, pubmed-author:AllardChristianC, pubmed-author:BastieJean-NoëlJN, pubmed-author:BerthouChristianC, pubmed-author:BoyerFrançoiseF, pubmed-author:CasassusPhilippeP, pubmed-author:CauvinJean-MichelJM, pubmed-author:DugayJacquelineJ, pubmed-author:FleschMichelM, pubmed-author:GhomariKamelK, pubmed-author:Groupe Ouest-Est Leucémies et Maladies du Sang (GOELAMS), pubmed-author:GuibaudIsabelleI, pubmed-author:HimberlinChantalC, pubmed-author:IsnardFrançoiseF, pubmed-author:Lacotte-ThierryLaurenceL, pubmed-author:LarosaFabriceF, pubmed-author:LeporrierMichelM, pubmed-author:MaigreMichelM, pubmed-author:RodonPhilippeP, pubmed-author:RollotFlorenceF, pubmed-author:RossiJean-FrançoisJF, pubmed-author:SlamaBorhaneB, pubmed-author:VillemagneBrunoB, pubmed-author:ZerbibRobertR
pubmed:issnType	Electronic
pubmed:volume	91
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1027-32
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:16885042-Angiogenesis Inhibitors, pubmed-meshheading:16885042-Double-Blind Method, pubmed-meshheading:16885042-France, pubmed-meshheading:16885042-Humans, pubmed-meshheading:16885042-Placebos, pubmed-meshheading:16885042-Primary Myelofibrosis, pubmed-meshheading:16885042-Reproducibility of Results, pubmed-meshheading:16885042-Research Design, pubmed-meshheading:16885042-Thalidomide
pubmed:year	2006
pubmed:articleTitle	Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
pubmed:affiliation	Groupe Ouest-Est Leucémies et Maladies du Sang. jean-francois.abgrall@chu-brest.fr
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase II